The COVID-19 pandemic that emerged in 2020 may affect the peripheral and central auditory system. According to studies in the literature, symptoms affecting the vestibulocochlear system such as sudden hearing loss, tinnitus, and vestibular neuritis are seen in individuals with COVID -19. 

The trigeminal nerve is one of twelve pairs of cranial nerves that attach to the brain. The name “trigeminal” literally means three twins and refers to the fact that the fifth cranial nerve has three major divisions: the ophthalmic (V1), the maxillary (V2), and the mandibular (V3) [1]. The trigeminal nerve is the major sensory nerve of the face and is the nerve of the first branchial arch.

Spinal cord infarction is extremely uncommon among vascular events, accounting for only 0.3-1% of all strokes and 5-8% of acute myelopathies. While deep vein thrombosis, pulmonary embolism, and stroke are commonly observed complications of COVID-19, spinal cord infarction is relatively rare.

The COVID-19 pandemic caused by the SARS-CoV-2 virus continues to impact populations worldwide, emphasizing the need for improved diagnostic and treatment strategies. Understanding the immune response and identifying early diagnostic markers are crucial in this endeavor. In this comprehensive commentary, we delve into a recent study that investigated the immune cell profiles and NLRP3 gene expression as potential diagnostic markers in COVID-19 patients. 

Several countries are in different phases of safely lifting the lockdowns necessitated by the Covid-19 pandemic and re-opening their economies. As they do so, it is important for authorities to recommend or impose some public health measures like social distancing and wearing face masks. Scientific articles are appearing in peer reviewed medical journals and even in the lay press on this topic. Some of the scientific definitions used in these articles might be erroneous.